Syndax Pharmaceuticals Inc
SNDX
Revenue
3.50M
▲3.50M∞%
12 Months ChangeAssets
476.95M
▼-66.08M▼-12.17%
3 Months ChangeLiabilities
42.61M
▼-8.53M▼-16.68%
3 Months ChangeFree Cash Flow
-20.04M
▼-20.04M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-01
Form 10-Q
ID: 0000950170-24-089241
2024-08-01
Form 8-K
ID: 0000950170-24-089235
2024-05-15
Form 8-K
ID: 0000950170-24-060462
2024-05-08
Form 10-Q
ID: 0000950170-24-055053
2024-05-08
Form 8-K
ID: 0000950170-24-055052
2024-03-18
Form 8-K
ID: 0000950170-24-032514
2024-02-27
Form 8-K
ID: 0000950170-24-021086
2023-12-20
Form 8-K
ID: 0000950170-23-071749
2023-12-15
Form 8-K
ID: 0001193125-23-296814
2023-12-12
Form 8-K
ID: 0000950170-23-069683